[Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
D000293:Adolescent; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003023:Cloxacillin / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010403:Penicillin Resistance; D012293:Rifampin / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D003023:Cloxacillin; D012293:Rifampin
Staphylococcus aureus resistente a cloxacilina: tratamiento con fosfomicina-rifampicina.